AVSuper's investment committee has appointed two new investment managers following a comprehensive review and due diligence.
Investment management company Martin Currie has been added to the fund's investment portfolio to manage a portion of AVSuper's emerging markets equities portfolio, while GMO will manage a portion of its defensive alternatives portfolio via the GMO Multi-Strategy Trust.
AVSuper investment committee officer Scott Malpass said Martin Currie's investment philosophy included a belief that market inefficiencies could be manipulated to maximise risk-adjusted returns.
"They provide a high-conviction, stock-focused portfolio driven by fundamental research," he said.
He said GMO targeted performance of UBS Australia Bank Bill Index plus 8 per cent with a standard deviation of 5 per cent.
"The Trust uses numerous underlying excess market (alpha) generating sources and seeks to achieve its investment objective with low volatility and correlation to traditional market indices," he said.
In February AVSuper awarded a $75 million mandate to Perpetual to manage a portion of its Australian equities portfolio.
The local super industry now commands more than $4 trillion in assets, boosted by impressive quarterly returns.
The industry fund has upped its investment in start-ups, helping to unlock the benefits of innovation and emerging technologies.
The chair of the Future Fund has slammed critics of the sovereign wealth’s new mandate as “factually incorrect”.
Super Review understands the Division 296 legislation could be facing the chopping block, with Labor said to be struggling to secure support ahead of the final sitting week of the year.